KYMR — Kymera Therapeutics, Inc. stock price, charts and financials

QT58Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
104.39
+4.08+4.07%
KYMRQT58Kymera Therapeutics, Inc.·NASDAQ
104.39+4.07%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jul 27, 20268-KCurrent report
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20263Initial statement of beneficial ownership
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264/AStatement of changes in beneficial ownership (amended)
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 26, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 26, 20264Statement of changes in beneficial ownership
Jun 25, 20268-KCurrent report
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership